Chugai Pharmaceutical Share Holder Equity 2020-2023 | CHGCY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Chugai Pharmaceutical share holder equity from 2020 to 2023. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Chugai Pharmaceutical share holder equity from 2020 to 2023. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Zoetis (ZTS)	$88.3B
Takeda Pharmaceutical (TAK)	$46.6B
Merck (MKGAF)	$23B
Astellas Pharma (ALPMY)	$21.6B
Sandoz Group AG (SDZNY)	$18.1B
Summit Therapeutics (SMMT)	$16.5B
United Therapeutics (UTHR)	$15.9B
Shionogi (SGIOY)	$13.3B
Neurocrine Biosciences (NBIX)	$11.7B
Catalent (CTLT)	$10.9B
Orion OYJ (ORINY)	$7.7B
Revolution Medicines (RVMD)	$7.3B
Jazz Pharmaceuticals (JAZZ)	$6.8B
Ionis Pharmaceuticals (IONS)	$6B
Hikma Pharmaceuticals Plc (HKMPF)	$5.7B
Madrigal Pharmaceuticals (MDGL)	$4.6B
Corcept Therapeutics (CORT)	$4.5B
Crinetics Pharmaceuticals (CRNX)	$4B
Dyne Therapeutics (DYN)	$3.5B
PTC Therapeutics (PTCT)	$2.9B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.6B
Arrowhead Pharmaceuticals (ARWR)	$2.4B
Catalyst Pharmaceuticals (CPRX)	$2.4B
Recursion Pharmaceuticals (RXRX)	$2B
Soleno Therapeutics (SLNO)	$1.9B
Centessa Pharmaceuticals (CNTA)	$1.8B
Xencor (XNCR)	$1.6B
Harrow (HROW)	$1.6B
BioCryst Pharmaceuticals (BCRX)	$1.6B
Cassava Sciences (SAVA)	$1.5B